Back to News
Market Impact: 0.42

ASE Technology vs. Amkor: Which Chip Packaging Stock Is the Better Buy?

Artificial IntelligenceTechnology & InnovationCorporate EarningsCorporate Guidance & OutlookCompany FundamentalsAnalyst EstimatesAnalyst InsightsTrade Policy & Supply Chain
ASE Technology vs. Amkor: Which Chip Packaging Stock Is the Better Buy?

ASE Technology posted Q1 2026 revenue of NT$173.7 billion, up 17% year over year, with ATM revenue up nearly 30% to a record NT$112.4 billion and operating income up 81%. Amkor also delivered a record quarter with revenue of $1.68 billion, up 27%, and EPS of 33 cents versus 9 cents a year ago, but ASE is viewed as the better long-term AI packaging play due to stronger projected earnings growth, slightly lower valuation, and better margin trajectory.

Analysis

The market is starting to re-rate advanced packaging as a quasi-picks-and-shovels AI bottleneck, but the second-order winner is not just the OSATs themselves: it is any vendor that can monetize tighter substrate, testing, and yield-management complexity. ASX looks better positioned to capture this because it has multiple revenue levers tied to the same AI buildout, which should smooth utilization and support margin resilience as new capacity comes online. AMKR is also benefiting, but its growth profile appears more back-half loaded and more exposed to execution slippage from customer ramp timing and supply-chain constraints.

The key distinction is earnings durability versus earnings pop. ASX’s estimate trajectory suggests a longer runway of operating leverage, which matters because packaging capex cycles often create a temporary peak in revenue growth before depreciation and ramp inefficiencies compress returns. AMKR’s near-term EPS upside may be stronger than the market expects, but the flattening 2027 outlook implies the current multiple is leaning heavily on confidence that every announced program converts on schedule.

Contrarianly, the consensus may be underestimating how quickly advanced packaging capacity can become a competitive arms race rather than a scarcity trade. If substrate supply, tooling, or AI customer qualification bottlenecks ease in 6-12 months, pricing power could normalize faster than investors are assuming, especially for the more capex-intensive names. In that scenario, the best risk-adjusted trade is not simply long the leaders, but long the company with the better margin conversion and balance-sheet flexibility when the cycle matures.

More News